*Cell count 0 and no flare.
†Study design: Two randomized, multicenter, double-masked, parallel-group, vehicle-controlled studies in 805 subjects with a combined grade of ≥3 for anterior chamber cells and flare 1 day after uncomplicated cataract surgery.
LOTEMAX® Ointment is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.
Click here for full Prescribing Information for LOTEMAX® Ointment.
References: 1. LOTEMAX Ointment [package insert]. Tampa, FL: Bausch & Lomb Incorporated. 2. Drugs@FDA.com website. https://www.accessdata.fda.gov/scripts/cder/daf/. Accessed May 30, 2018.
Click here for IMPORTANT SAFETY INFORMATION